Received Feb 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | LA |
fever; Flu like symptoms including; shivering; headache; body aches; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of fever in a 52-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. On 14-FEB-2025, the patient received Shingrix (left deltoid). On 14-FEB-2025, less than a day after receiving Shingrix, the patient experienced fever (Verbatim: fever), influenza-like symptoms (Verbatim: Flu like symptoms including), shivering (Verbatim: shivering), headache (Verbatim: headache) and general body pain (Verbatim: body aches). On 14-FEB-2025, the outcome of the fever, influenza-like symptoms, shivering, headache and general body pain were resolved. The reporter considered the fever, influenza-like symptoms, shivering, headache and general body pain to be related to Shingrix. The company considered the fever, influenza-like symptoms, shivering, headache and general body pain to be related to Shingrix. Additional Information: GSK Receipt Date: 14-FEB-2025 The reporter reported that patient received the Shingrix vaccine and experienced Flu like symptoms including fever, shivering, headache, body aches.